Patents Assigned to Stuart L. Weg
  • NMDA RECEPTOR ANTAGONIST FORMULATION WITH REDUCED NEUROTOXICITY
    Publication number: 20140171514
    Abstract: The present invention is directed to pharmaceutical compositions of effective amounts of NMDA receptor antagonists and preservative for the administration to a patient in need of effective analgesia and anesthesia. The compositions of the invention advantageously do not cause any significant neurotoxicity. The preferred NMDA receptor antagonist is ketamine. The preferred preservative is benzalkonium chloride.
    Type: Application
    Filed: February 21, 2014
    Publication date: June 19, 2014
    Applicant: Stuart L. Weg
    Inventors: Fred H. Mermelstein, Randi Albin